Issue Price
₹130
Per Share
GMP
NIL
Grey Market
Est. Listing
₹130
Expected Price
Min. Application
₹260,000
2 lots × 1000 shares
Incorporated in 2013, Maharashtra- based Transpact Enterprises Limited is a biotechnology startUp. It provides comprehensive & cost-effective products and solutions to specially-abled people. The company is continuously working towards technological innovations and interventions to improve their products. Transpact Enterprises mainly designs, develops and distributes Vestibulator, a therapeutic device. The device has been invented by the Society for Innovation and Entrepreneurship, lIT Bombay. And, Transpact Enterprises holds a license to carry out the commercial activities of Vestibulator. It is a co-patented technology of the company and IRCC-IIT Bombay. Vestibulator: It is a therapeutic device to offer optimum vestibular stimulation for the cases with vestibular dysfunctions. The company outsources the manufacturing of the device along with the design details to a 3rd party. With the help of advanced software, the company offers customized device solutions for patients.Competitive Strengths1. User Friendly device with unique features 2. Technical foundation to offer customized device 3. Quality assured and certified device
Transpact Enterprises Ltd. proposes to utilise the net proceeds from the Issue for the following objects:
| Category | Shares Offered | % Issue | Amount (₹ Cr)* | Subscription |
|---|---|---|---|---|
| Market Maker | 6,000 | — | ₹0.08 Cr | — |
| TOTAL | 104,000 | 100.00% | ₹1.35 Cr | — |
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 1,000 | ₹130,000 |
| Retail (Max) | 13 | 13,000 | ₹1,690,000 |
| sNII (Min) | 14 | 14,000 | ₹1,820,000 |
| bNII (Min) | 68 | 68,000 | ₹8,840,000 |
| Particulars | 31-Dec-18 | 31-Mar-18 | 31-Mar-17 |
|---|---|---|---|
| Revenue from Operations | 13.00 | N/A | N/A |
| EBITDA | N/A | N/A | N/A |
| Profit After Tax (PAT) | 7.10 | 9.15 | 4.53 |
| Net Worth | N/A | N/A | N/A |
| Total Assets | 51.92 | 46.98 | 23.60 |
| Reserves & Surplus | N/A | N/A | N/A |
| Total Borrowings | N/A | N/A | N/A |